← All organizations

Modis Therapeutics, Inc.

For profitWebsite ↗

Also known as: Modis Therapeutics | Modis Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2020

Acquired by Zogenix, Inc. → UCB on Aug 26, 2019

Timeline

2010s

Jan 1, 2016
Modis Therapeutics, Inc.— Founded
Aug 26, 2019
Zogenix, Inc.— Acquired By

2020s

Jan 20, 2022
UCB— Now

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

zidovudine

Recent trials (4)

NCT04581733Lead sponsorPhase 3Dec 31, 2020
NCT04581733Study directorPhase 3Dec 31, 2020
NCT03845712Lead sponsorPhase 2Jul 1, 2019
NCT03845712Study directorPhase 2Jul 1, 2019

Details

Founded: Oakland, CA, US Jan 1, 2016
Last known activity: Dec 31, 2020